03.08.2012 - German healthcare conglomerate Fresenius may raise its 2012 profit outlook for a third time this year as its injectable generic drugs unit Kabi continues to benefit from rivals'...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)